How an Innovative Statistical Methodology Enables More Patient-Centric Design and Analysis of Clinical Trials

Clinical trials are critical for assessing new treatments in terms of their potential benefits for patients’ health and for their likelihood of financial success if marketed. Yet, the traditional approach focusing on a single primary endpoint may mean lengthy trials that often fail to capture the full spectrum of the treatment effects that are crucial to patient well-being